Menu Back toFacilitating-Nonclinical-Data-Sharing-and-Access-Across-the-Industry

DIA 2018 Global Annual Meeting


Facilitating Nonclinical Data Sharing and Access Across the Industry

    Session Chair(s)
      William  Houser

      William Houser

      • Capability Manager
      • Bristol-Myers Squibb, United States
    This session will present an overview of the SEND components required for US FDA applications and provide a foundational understanding of how to review regulatory applications for SEND compliance. This session will present the core capabilities, use cases, and principles driving the Toxicology Data Sharing Initiative.
    Learning Objective : Understand the SEND components required for US FDA applications. Apply this knowledge to review regulatory applications for SEND compliance
    Speaker(s)
      William  Houser

      BioCelerate Toxicology Data Sharing Initiative: Development of a Centralized, Searchable Preclinical Data Repository

      William Houser

      • Capability Manager
      • Bristol-Myers Squibb, United States
      Kaitlyn Nicole Riffel, MSc

      US Regulatory Compliance With the Standard For Exchange of Nonclinical Data (SEND)

      Kaitlyn Nicole Riffel, MSc

      • Consultant, Scientific Consulting
      • Cardinal Health Regulatory Sciences, United States